Socinski MA - Search Results

1

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.

Bodor JN, Patel JD, Wakelee HA, Levy BP, Borghaei H, Pellini B, Costello MR, Dowell JE, Finley G, Huang CH, Neal JW, Nieva JJ, Puri S, Socinski MA, Thomas C, Ross EA, Litwin S, Clapper ML, Treat J. Bodor JN, et al. Among authors: socinski ma. Clin Lung Cancer. 2023 Nov;24(7):e242-e246. doi: 10.1016/j.cllc.2023.05.003. Epub 2023 May 11. Clin Lung Cancer. 2023. PMID: 37451930 Free PMC article. Clinical Trial.

2

Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.

Socinski MA, Neubauer MA, Olivares J, Ketchel S, Tynan M, Moore M, Lee JH, Davis K, Schell M, Garfield D. Socinski MA, et al. Lung Cancer. 2003 Apr;40(1):91-7. doi: 10.1016/s0169-5002(02)00527-5. Lung Cancer. 2003. PMID: 12660013 Clinical Trial.

3

Irinotecan in non-small-cell lung cancer: status of ongoing trials.

Socinski MA. Socinski MA. Clin Lung Cancer. 2002 Nov;4 Suppl 1:S15-20. doi: 10.3816/clc.2002.s.017. Clin Lung Cancer. 2002. PMID: 14659036

4

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial.

Socinski MA, Sandler AB, Miller LL, Locker PK, Hanover CK, Elfring GL, Israel VK, Pirotta N, Natale RB. Socinski MA, et al. Clin Lung Cancer. 2001 May;2 Suppl 2:S26-33. doi: 10.3816/clc.2001.s.005. Clin Lung Cancer. 2001. PMID: 14725727

5

Second-line gemcitabine in refractory stage IV non small-cell lung cancer: a phase II trial.

Gillenwater HH, Tynan M, Natoli S, Schell MJ, Socinski MA. Gillenwater HH, et al. Among authors: socinski ma. Clin Lung Cancer. 2000 Nov;2(2):133-8. doi: 10.3816/clc.2000.n.026. Clin Lung Cancer. 2000. PMID: 14731324

6

Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.

Socinski MA. Socinski MA. Clin Lung Cancer. 2004 Mar;5(5):274-89. doi: 10.3816/CLC.2004.n.007. Clin Lung Cancer. 2004. PMID: 15086966 Review.

7

Adjuvant therapy of resected non-small-cell lung cancer.

Socinski MA. Socinski MA. Clin Lung Cancer. 2004 Nov;6(3):162-9. doi: 10.3816/CLC.2004.n.029. Clin Lung Cancer. 2004. PMID: 15555217 Review.

8

Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.

Stinchcombe TE, Lee CB, Socinski MA. Stinchcombe TE, et al. Among authors: socinski ma. Clin Lung Cancer. 2006 May;7 Suppl 4:S111-7. doi: 10.3816/clc.2006.s.002. Clin Lung Cancer. 2006. PMID: 16764751 Review.

9

Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.

Lee CB, Stinchcombe TE, Rosenman JG, Socinski MA. Lee CB, et al. Among authors: socinski ma. Clin Lung Cancer. 2006 Nov;8(3):195-202. doi: 10.3816/CLC.2006.n.047. Clin Lung Cancer. 2006. PMID: 17239295 Review.

10

Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.

Lynch TJ Jr, Blumenschein GR Jr, Engelman JA, Espinoza-Delgado I, Govindan R, Hanke J, Hanna NH, Heymach JV, Hirsch FR, Janne PA, Lilenbaum RC, Natale RB, Riely GJ, Sequist LV, Shapiro GI, Shaw A, Shepherd FA, Socinski M, Sorensen AG, Wakelee HA, Weitzman A. Lynch TJ Jr, et al. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S107-12. doi: 10.1097/JTO.0b013e318174e9d3. J Thorac Oncol. 2008. PMID: 18520291 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters